BioMEANDER (Q3989231): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Fix Beneficiary from Netherlands) |
(Changed an Item: Fix Beneficiary from Netherlands) |
||
Property / beneficiary name (string) | |||
Universiteit Twente | |||
Property / beneficiary name (string): Universiteit Twente / rank | |||
Normal rank | |||
Property / beneficiary | |||
Property / beneficiary: Q3985142 / rank | |||
Normal rank |
Revision as of 09:28, 16 December 2021
Project Q3989231 in Netherlands
Language | Label | Description | Also known as |
---|---|---|---|
English | BioMEANDER |
Project Q3989231 in Netherlands |
Statements
306,823.43 Euro
0 references
1,998,722.03 Euro
0 references
15.351 percent
0 references
1 July 2017
0 references
30 June 2020
0 references
Lead Pharma Holding
0 references
LioniX
0 references
Surfix BV
0 references
Universiteit Twente
0 references
6534 AT
0 references
7500 AL
0 references
6700 AG
0 references
7500 AE
0 references
Binnen het BioMeander project wordt een zeer gevoelig screening- en detectieplatform, gebaseerd op een asymmetrische Mach-Zehnder interferometer, voor biologische testen ontwikkeld.De gezamenlijke technische innovaties van Surfix en LioniX leide... (Dutch)
0 references
Within the BioMeander project, a highly sensitive screening and detection platform, based on an asymmetric Mach-Zehnder interferometer, is being developed for biological testing.The joint technical innovations of Surfix and LioniX... (English)
15 December 2021
0 references
Dans le cadre du projet BioMeander, une plateforme de dépistage et de détection hautement sensible, basée sur un interféromètre Mach-Zehnder asymétrique, est en cours de développement pour les tests biologiques.Les innovations techniques conjointes de Surfix et LioniX... (French)
15 December 2021
0 references
Innerhalb des BioMeander-Projekts wird eine hochempfindliche Screening- und Detektionsplattform, basierend auf einem asymmetrischen Mach-Zehnder-Interferometer, für biologische Tests entwickelt.Die gemeinsamen technischen Innovationen von Surfix und LioniX... (German)
15 December 2021
0 references
Identifiers
OP-2014-2023-Oost-PROJ-00697
0 references